About B²O

B²O Pharmaceutical
Specialized in AI-Driven Clinical & Quantitative Pharmacology Research

B²O Pharmaceutical is an innovative pharmaceutical R&D company focused on artificial intelligence (AI)-driven clinical pharmacology and quantitative pharmacology. Our team consists of globally oriented senior experts from multinational pharmaceutical companies and top academic institutions, specializing in AI and quantitative pharmacology modeling. Following a problem-driven R&D philosophy, we provide professional new drug development services spanning clinical pharmacology, quantitative pharmacology and artificial intelligence, with all work fully aligned with international standards and global regulatory requirements.

We conduct AI-enabled clinical and quantitative pharmacology research using innovative virtual drug development technologies. We have independently developed our proprietary AI-PBPK modeling platform: B²O Software Platform.